Shoulder rotator cuff injury.
Conditions
Interventions
Observation Group 1 (Control Group):The patient did not receive local infiltrative anesthesia for pain relief.
Observation Group 2 (Bupivacaine Liposome Group):The patient received local infiltrative anesthesia for pain relief using bupivacaine liposomes.
Observation Group 3 ("Cocktail" Group):The patient received local infiltrative anesthesia for pain relief using a "cocktail" approach.
Sponsors
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Male or female, aged >= 18 years old. 2. Diagnosed with a full-thickness rotator cuff tear and undergoing unilateral arthroscopic rotator cuff repair using a double-row fixation technique under general anesthesia. 3. Classified as American Society of Anesthesiologists (ASA) physical status grade I-III, possessing a certain level of education, with a good understanding of the Chinese language (both spoken and written), capable of unimpeded communication with medical staff, able to properly comprehend the Visual Analog Scale (VAS) for pain assessment, and willing to actively cooperate with relevant examinations. 4. The patient voluntarily participates in this trial, signs the informed consent form personally, and cooperates in completing all study evaluations.
Exclusion criteria
Exclusion criteria: 1. Allergy or intolerance to local anesthetics; 2. Recent use of narcotic analgesics for more than three weeks; 3. Presence of neuromuscular diseases in the operative limb; patients with other comorbidities that may affect postoperative rehabilitation; 4. Patients who have received treatment for coronary artery disease, vascular stent placement, deep vein thrombosis, pulmonary embolism, myocardial infarction, or ischemic stroke within the past six months; 5. Presence of severe hepatic or renal dysfunction, coagulopathy, arrhythmia, infection, or other surgical contraindications; 6. Patients with any neurological or psychiatric disorders that may affect postoperative pain or interfere with study evaluations; 7. Patients with a history of abuse, misuse, or dependence on opioid analgesics, other prescription drugs, illicit drugs, or alcohol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Visual Analog Scale (VAS) was applied to compare the mean VAS scores at rest between the two groups at 24, 48, and 72 hours postoperatively.; | — |
Secondary
| Measure | Time frame |
|---|---|
| The mean Visual Analog Scale (VAS) scores during activity at 6, 24, 48, and 72 hours postoperatively.;VAS scores during both activity and rest at each postoperative time point (6, 24, 48, and 72 hours after surgery;The shoulder abduction angles of patients at 24, 48, and 72 hours postoperatively.;The sleep conditions of patients in the three days following surgery.;QoR-15 score at 72 hours postoperatively.;SPASDI score at 72 hours postoperatively.;The time when the patient first received analgesics after surgery.; | — |
Countries
China
Contacts
Public ContactLi Yi
Department of Joint Surgery and Sports Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, China
Outcome results
None listed